Ozanimod: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 8, p. 841, doi. 10.1007/s40265-020-01319-7
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2020 AND VI 80 AND IP 8
Results: 9
1
2
Tirabrutinib: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 8, p. 835, doi. 10.1007/s40265-020-01318-8
- By:
- Publication type:
- Article
3
Therapeutic Strategies to Treat or Prevent Off Episodes in Adults with Parkinson's Disease.
- Published in:
- Drugs, 2020, v. 80, n. 8, p. 775, doi. 10.1007/s40265-020-01310-2
- By:
- Publication type:
- Article
4
Tepotinib: First Approval.
- Published in:
- Drugs, 2020, v. 80, n. 8, p. 829, doi. 10.1007/s40265-020-01317-9
- By:
- Publication type:
- Article
5
Levodopa Inhalation Powder: A Review in Parkinson's Disease.
- Published in:
- Drugs, 2020, v. 80, n. 8, p. 821, doi. 10.1007/s40265-020-01307-x
- By:
- Publication type:
- Article
6
Uveitis Therapy: The Corticosteroid Options.
- Published in:
- Drugs, 2020, v. 80, n. 8, p. 765, doi. 10.1007/s40265-020-01314-y
- By:
- Publication type:
- Article
7
A New Paradigm for Achieving a Rapid Antidepressant Response.
- Published in:
- Drugs, 2020, v. 80, n. 8, p. 755, doi. 10.1007/s40265-020-01303-1
- By:
- Publication type:
- Article
8
ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3–5: A Network Meta-Analysis of Randomised Clinical Trials.
- Published in:
- Drugs, 2020, v. 80, n. 8, p. 797, doi. 10.1007/s40265-020-01290-3
- By:
- Publication type:
- Article
9
Cemiplimab: A Review in Advanced Cutaneous Squamous Cell Carcinoma.
- Published in:
- Drugs, 2020, v. 80, n. 8, p. 813, doi. 10.1007/s40265-020-01302-2
- By:
- Publication type:
- Article